loading page

WHILE STUDIES ON COVID-19 VACCINE IS ONGOİNG; THE PUBLIC’S THOUGHTS AND ATTITUDES TO THE FUTURE COVID-19 VACCINE
  • +3
  • BÜŞRA AKARSU,
  • DİLARA CANBAY ÖZDEMİR,
  • Duygu AYHAN BASER,
  • Hilal Aksoy,
  • İzzet Fidancı,
  • Mustafa Cankurtaran
BÜŞRA AKARSU
Hacettepe University Faculty of Medicine

Corresponding Author:busrakarsu44@gmail.com

Author Profile
DİLARA CANBAY ÖZDEMİR
Hacettepe University Faculty of Medicine
Author Profile
Duygu AYHAN BASER
Hacettepe University Faculty of Medicine
Author Profile
Hilal Aksoy
Hacettepe University Faculty of Medicine
Author Profile
İzzet Fidancı
Author Profile
Mustafa Cankurtaran
Hacettepe University
Author Profile

Abstract

OBJECTİVE In this study, we aim to investigate the thoughts and attitudes of individuals towards the future COVID-19 vaccine. METHODS This descriptive study was carried out on the web between 10/06/2020 - 10/07/2020. The sample constitutes all individuals above 18 years of age using social media and smartphone. The e-survey form was shared by the researchers via the web for a month, and those who completed the survey were included in the study and formed the sample of the research. RESULTS 759 were participated. 49.7% of the participants stated to be vaccinated; 38.4% of them stated to be vaccinated their children against COVID-19; if the vaccine for COVID-19 is developed. The request for the COVID 19 vaccine had relationship with gender, occupation, health insurance, anxiety level, having children, willing to get vaccinated for their children. “Afraid of the side effects of vaccine”, “don’t think it can be reliable as it will be a new vaccine” and “COVID-19 infection is a biological weapon and the vaccine will serve those who produce this virus” were the most common reasons for rejection of vaccine. CONCLUSION In our study afraid of the side effects of vaccine and not thinking it can be reliable as it will be a new vaccine is the most reasons of indecision and rejection about COVID 19 vaccine. In order for the future COVID 19 vaccination campaign to not fail, media, politicians, healthcare professionals should closely follow the vaccination development processes, inform the public transparently and consider public’s concerns.
17 Aug 2020Submitted to International Journal of Clinical Practice
18 Aug 2020Submission Checks Completed
18 Aug 2020Assigned to Editor
20 Sep 2020Reviewer(s) Assigned
24 Sep 2020Review(s) Completed, Editorial Evaluation Pending
27 Oct 20201st Revision Received
29 Oct 2020Reviewer(s) Assigned
29 Oct 2020Submission Checks Completed
29 Oct 2020Assigned to Editor
05 Nov 2020Review(s) Completed, Editorial Evaluation Pending
30 Nov 2020Editorial Decision: Accept